MyFinsight
Home
About
Contact
ltrn: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, LTRN has $13,626,810 in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Dollar
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
13,626,810
17,420,292
Total stockholders equity
9,586,838
12,522,405
Total liabilities and stockholders equity
13,626,810
17,420,292
Unit: Dollar
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$1,098,429
Marketable securities
$3,973,090
Cash and cash
equivalents
$8,389,486
Other assets
$36,738
Operating lease
right-of-use assets
$93,090
Property and equipment,
net
$35,977
Total current assets
$13,461,005
Total assets
$13,626,810
Total liabilities and
stockholders equity
$13,626,810
Total stockholders
equity
$9,586,838
Total liabilities
$4,039,972
Accumulated deficit
-$89,070,838
Accumulated other
comprehensive income
$40,333
Additional paid-in capital
$98,616,239
Total current
liabilities
$4,039,972
Common stock
(25,000,000 authorized at...
$1,104
Operating lease
liabilities, current
$93,954
Accounts payable and
accrued expenses
$3,946,018
Subscribe for Financial Insights
Lantern Pharma Inc. (LTRN)
Lantern Pharma Inc. (LTRN)